戈利穆马布诱导的后部可逆脑病综合征 (PRES):基于病例的综述
Ezgi Çimen Güneş1, Seda Çolak2, Emre Tekgöz2
1Department of Internal Medicine, Division of Rheumatology, Gulhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey. dr.ezgicimen@gmail.com.
Clinical rheumatology
|September 15, 2023
概括
后回性脑病综合征 (PRES) 可能发生在治疗结性脊髓炎后的golimumab治疗后. 这份案例报告强调了在抗瘤缩因子α治疗期间考虑在患有神经症状的患者中使用PRES的重要性.
科学领域:
- 神经学 神经学
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 后回性脑病综合征 (PRES) 是一种神经疾病.
- 戈利穆马布是一种抗瘤缩因子-α (抗TNF-α) 药物,可治疗诸如结性脊髓炎 (AS) 等类风湿性疾病.
更多相关视频
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
7.8K
06:19Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
3.7K
